Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.15Last Year’s EPS
0.22Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: -3.56%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance, with notable achievements in debt reduction and improvements in the Respiratory and Diabetes Health segments. However, overall revenue and adjusted EBITDA declines, as well as challenges in the Sleep Health segment, balanced the positive aspects. The sentiment is neutral, reflecting both progress and ongoing challenges.Company Guidance
During the AdaptHealth First Quarter 2025 earnings call, the company provided a comprehensive overview of their financial performance and guidance. Revenue in the first quarter reached $777.9 million, exceeding the midpoint of their guidance range by $13.1 million, despite a 1.8% decline from the previous year. Adjusted EBITDA was $127.9 million, aligning with the upper half of the guidance range, though it decreased by 19.3% year-over-year, with the adjusted EBITDA margin reported at 16.4%. The company reported a slight free cash flow deficit of $0.1 million, a significant improvement from the negative $38.9 million in the prior year. For the full year 2025, AdaptHealth anticipates revenue between $3.18 billion and $3.32 billion and adjusted EBITDA of $665 million to $705 million, with a free cash flow forecast between $180 million and $220 million. The company is reducing its full-year revenue expectations by $40 million and adjusted EBITDA by $5 million due to the divestiture of certain incontinence assets. AdaptHealth continues to strengthen its financial position, reducing its debt by $25 million during the quarter, and is on track to achieve a net leverage ratio target of 2.5 times.Revenue Exceeds Guidance
First quarter revenue exceeded the midpoint of the guidance range by $13.1 million, driven by stronger than anticipated revenues in the Respiratory Health and Diabetes Health segments.
Significant Debt Reduction
AdaptHealth reduced its debt balance by another $25 million in Q1 2025, bringing total debt repayment to $195 million over the last five quarters.
Improvement in Diabetes Health Segment
The Diabetes Health team showed signs of recovery with a second consecutive quarter of sequential improvement in new starts and the lowest resupply attrition rate in two years.
Strong Respiratory Health Segment Performance
First quarter Respiratory Health segment net revenue increased 3.3% compared to the prior year quarter, with a record oxygen census of 325,000 patients.
AHCO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AHCO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $8.70 | $8.85 | +1.72% |
Feb 25, 2025 | $8.55 | $10.64 | +24.44% |
Nov 05, 2024 | $10.15 | $9.18 | -9.56% |
Aug 06, 2024 | $10.97 | $8.66 | -21.06% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AdaptHealth (AHCO) report earnings?
AdaptHealth (AHCO) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is AdaptHealth (AHCO) earnings time?
AdaptHealth (AHCO) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AHCO EPS forecast?
AHCO EPS forecast for the fiscal quarter 2025 (Q2) is 0.15.
